Senti Biosciences Holdings
SNTI
16 hedge funds and large institutions have $3.23M invested in Senti Biosciences Holdings in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
34% more capital invested
Capital invested by funds: $2.41M → $3.23M (+$824K)
14% more funds holding
Funds holding: 14 → 16 (+2)
3.21% less ownership
Funds ownership: 23.27% → 20.06% (-3.2%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$165K |
| 2 |
VF
Virtu Financial
New York
|
+$42.6K |
| 3 |
State Street
Boston,
Massachusetts
|
+$31.9K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$27K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$642 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$564K |
| 2 |
IC
Intel Corp
Santa Clara,
California
|
-$109K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.26K |
| 4 |
HI
Harbour Investments
Madison,
Wisconsin
|
-$3.39K |
| 5 |
Barclays
London,
United Kingdom
|
-$1.5K |
SNTI Hedge Fund Activity: Q4 2024 in Review
16 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Senti Biosciences Holdings (SNTI) for Q4 2024, worth a combined $3.23M — up 34% from $2.41M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new SNTI positions and 2 closed out — a net gain of 2 holders — while 2 added to existing stakes and 6 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $165K. The largest seller was ARK Investment Management, cutting an estimated $564K.
- 16 institutional investors held Senti Biosciences Holdings (SNTI) as of Q4 2024, up from 14 in Q3 2024.
- Funds reported $3.23M of Senti Biosciences Holdings stock for Q4 2024, up 34% quarter-over-quarter.
- 4 funds opened new Senti Biosciences Holdings positions in Q4 2024 and 2 closed out, a net change of +2 holders.
- The largest Senti Biosciences Holdings buyer in Q4 2024 was Renaissance Technologies, an estimated $165K added.
- The largest Senti Biosciences Holdings seller in Q4 2024 was ARK Investment Management, an estimated $564K sold.
Based on aggregated 13F filings for Q4 2024.